International standardisation of quantitative real-time RT-PCR for BCR-ABL

Leukemia Research

Volumn 32, Issue 3, 2008, Pages 505-506

  Cross, Nicholas C P ^a   Hughes, Timothy P ^b   Hochhaus, Andreas ^c   Goldman, John M ^d  

^a SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^b HANSON INSTITUTE   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; BETA 2 MICROGLOBULIN; BETA GLUCURONIDASE; COMPLEMENTARY DNA; RNA;

CELL TYPE; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; GENETIC TRANSCRIPTION; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; LETTER; METAPHASE CHROMOSOME; PATIENT MONITORING; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; INTERNATIONAL COOPERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 39749199769     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.03.031     Document Type: Letter

References (7)

1. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) research0034.1-0034.11
2. Beillard E., Pallisgaard N., van der Velden V.H., Bi W., Dee R., van der Schoot E., et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-a Europe against cancer program. Leukemia 17 (2003) 2474-2486
3. Rulcova J., Zmekova V., Zemanova Z., Klamova H., and Moravcova J. The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR. Leuk Res 31 (2007) 483-491
4. Emig M., Saussele S., Wittor H., Weisser A., Reiter A., Willer A., et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 13 (1999) 1825-1832
5. Hughes T.P., Kaeda J., Branford S., Rudski Z., Hochhaus A., Hensley M.L., et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. New Engl J Med 349 (2003) 1421-1430
6. Hughes T., Deininger M., Hochhaus A., et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors - recommendations for 'harmonizing' current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108 (2006) 28-37
7. Iacobucci I., Galletti L., Amabile M., Soverini S., Baccarani M., and Martinelli G. Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio. Haematologica 92 (2007) 429-430